📌 Key Takeaways
- Topic: Silica as a Carrier: Converting Liquids into Free-Flowing Powders
- Keywords: hydrophobic silica powder
- Published: 2026-11-20 09:06:55
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
How to Choose a Silica Supplier: Key Criteria, Certifications and Red Flags
- Colloidal Silica Supplier: How to Choose by Particle Size, Stability and pH
- Fumed Silica Alternatives: Cost-Effective Substitutes and How They Compare
- What Is the Refractive Index of Silica? Values for Fused Silica, Quartz and Amorphous Silica
- High Purity Quartz Supplier: Global Sources, Purity Grades and Selection Tips
How to Disperse Fumed Silica: Methods, Equipment and Common Mistakes
What is silica (SiO₂)?
silica for printing ink
What is the difference between fumed silica and precipitated silica?
what is silica Tanev, P. T. & Pinnavaia, T. J. Biomimetic assembly of porous lamellar silica molecular sieves with a vesicular particle architecture. Supramol. Sci. 5, 399-404 (1998). Article CAS Google Scholar
What drives silica raw material prices?
respirable crystalline silica OSHA The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.